Literature DB >> 18941205

Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8+ T cells.

Kerstin A Sauer1, Joachim H Maxeiner, Roman Karwot, Petra Scholtes, Hans A Lehr, Mark Birkenbach, Richard S Blumberg, Susetta Finotto.   

Abstract

EBV-induced gene 3 (EBI-3) codes for a soluble type I receptor homologous to the p40 subunit of IL-12 that is expressed by APCs following activation. In this study, we assessed the role of EBI-3 in a model of lung melanoma metastasis. Intravenous injection of the B16-F10 cell line resulted in a significant reduction of lung tumor metastasis in EBI-3(-/-) recipient mice compared with wild-type mice. The immunological finding accompanying this effect was the expansion of a newly described cell subset called IFN-gamma producing killer dendritic cells associated with CD8(+) T cell responses in the lung of EBI-3(-/-) mice including IFN-gamma release and TNF-alpha-induced programmed tumor cell death. Depletion of CD8(+) T cells as well as targeting T-bet abrogated the protective effects of EBI-3 deficiency on lung melanoma metastases. Finally, adoptive transfer of EBI-3(-/-) CD8(+) T cells into tumor bearing wild-type mice inhibited lung metastasis in recipient mice. Taken together, these data demonstrate that targeting EBI-3 leads to a T-bet-mediated antitumor CD8(+) T cell responses in the lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941205      PMCID: PMC3996841          DOI: 10.4049/jimmunol.181.9.6148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells.

Authors:  Rhys S Allan; Chris M Smith; Gabrielle T Belz; Allison L van Lint; Linda M Wakim; William R Heath; Francis R Carbone
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

3.  Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.

Authors:  Atsunobu Takeda; Shinjiro Hamano; Atsushi Yamanaka; Toshikatsu Hanada; Tatsuro Ishibashi; Tak W Mak; Akihiko Yoshimura; Hiroki Yoshida
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 4.  Heterogeneity of CD4(+) and CD8(+) T cells.

Authors:  David L Woodland; Richard W Dutton
Journal:  Curr Opin Immunol       Date:  2003-06       Impact factor: 7.486

5.  Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus.

Authors:  Gabrielle T Belz; Christopher M Smith; Lauren Kleinert; Patrick Reading; Andrew Brooks; Ken Shortman; Francis R Carbone; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-26       Impact factor: 11.205

Review 6.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

7.  Antigen-driven effector CD8 T cell function regulated by T-bet.

Authors:  Brandon M Sullivan; Amy Juedes; Susanne J Szabo; Matthias von Herrath; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

8.  T-bet plays a key role in NK-mediated control of melanoma metastatic disease.

Authors:  Miriam B F Werneck; Geanncarlo Lugo-Villarino; Eun Sook Hwang; Harvey Cantor; Laurie H Glimcher
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

9.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

View more
  18 in total

Review 1.  Interleukin-35: Expanding Its Job Profile.

Authors:  Deepali V Sawant; Kristia Hamilton; Dario A A Vignali
Journal:  J Interferon Cytokine Res       Date:  2015-04-28       Impact factor: 2.607

2.  IL-27 confers a protumorigenic activity of regulatory T cells via CD39.

Authors:  Young-Jun Park; Heeju Ryu; Garam Choi; Byung-Seok Kim; Eun Sook Hwang; Hun Sik Kim; Yeonseok Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

3.  Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.

Authors:  Zhenzhen Liu; Jin-Qing Liu; Yun Shi; Xiaotong Zhu; Zhihao Liu; Ming-Song Li; Jianhua Yu; Lai-Chu Wu; Yukai He; Guoqiang Zhang; Xue-Feng Bai
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

4.  A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Authors:  S Reppert; I Boross; M Koslowski; Ö Türeci; S Koch; H A Lehr; S Finotto
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

5.  IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors.

Authors:  Jonathan H DeLong; Aisling O'Hara Hall; Matt Rausch; Devapregasan Moodley; Joseph Perry; Jeongho Park; Anthony T Phan; Daniel P Beiting; Ross M Kedl; Jonathan A Hill; Christopher A Hunter
Journal:  Immunohorizons       Date:  2019-01-15

Review 6.  The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Authors:  Elia D Tait Wojno; Christopher A Hunter; Jason S Stumhofer
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

7.  NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.

Authors:  Silvana Morello; Rosalinda Sorrentino; Antonella Montinaro; Antonio Luciano; Piera Maiolino; Anta Ngkelo; Claudio Arra; Ian M Adcock; Aldo Pinto
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

8.  Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.

Authors:  Henok Eyob; Huseyin Atakan Ekiz; Yoko S Derose; Susan E Waltz; Matthew A Williams; Alana L Welm
Journal:  Cancer Discov       Date:  2013-04-23       Impact factor: 39.397

9.  Tumor antigen cross-presentation and the dendritic cell: where it all begins?

Authors:  Alison M McDonnell; Bruce W S Robinson; Andrew J Currie
Journal:  Clin Dev Immunol       Date:  2010-10-13

10.  EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin.

Authors:  Izuru Mizoguchi; Mio Ohashi; Hideaki Hasegawa; Yukino Chiba; Naoko Orii; Shinya Inoue; Chiaki Kawana; Mingli Xu; Katsuko Sudo; Koji Fujita; Masahiko Kuroda; Shin-Ichi Hashimoto; Kouji Matsushima; Takayuki Yoshimoto
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.